Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Miller

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Macromolecules|March 18, 2024
Low-Viscosity Route to High-Molecular-Weight Water-Soluble Polymers: Exploiting the Salt Sensitivity of Poly(<i>N</i>-acryloylmorpholine)Rory J McBride, Elisa Geneste, Andi Xie, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strainsJohn F Miller, Eric S Furfine, Mary H Hanlon, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2009
Substituted tetrahydro-beta-carbolines as potential agents for the treatment of human papillomavirus infectionJohn F Miller, Elizabeth M Turner, Ronald G Sherrill, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2005
Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitorsRonald G Sherrill, Eric S Furfine, Richard J Hazen, et al.
Bioorganic & Medicinal Chemistry Letters|July 31, 2009
Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1Kristjan S Gudmundsson, Paul R Sebahar, Leah D'Aurora Richardson, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2010
Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1John G Catalano, Kristjan S Gudmundsson, Angilique Svolto, et al.
Journal of Medicinal Chemistry|November 15, 2013
Imidazopyridazine hepatitis C virus polymerase inhibitors. Structure-activity relationship studies and the discovery of a novel, traceless prodrug mechanismMartin Leivers, John F Miller, Stephanie A Chan, et al.
Biochemistry|November 10, 2004
Inhibition of wild-type and mutant human immunodeficiency virus type 1 proteases by GW0385 and other arylsulfonamidesMary H Hanlon, David J T Porter, Eric S Furfine, et al.
The Journal of Organic Chemistry|November 1, 2013
Synthesis of HCV replicase inhibitors: base-catalyzed synthesis of protected α-hydrazino esters and selective aerobic oxidation with catalytic Pt/Bi/C for synthesis of imidazole-4,5-dicarbaldehydeRoy K Bowman, Andrew D Brown, Jannine H Cobb, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2006
Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385John F Miller, C Webster Andrews, Michael Brieger, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Macromolecules|March 18, 2024
Low-Viscosity Route to High-Molecular-Weight Water-Soluble Polymers: Exploiting the Salt Sensitivity of Poly(<i>N</i>-acryloylmorpholine)Rory J McBride, Elisa Geneste, Andi Xie, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strainsJohn F Miller, Eric S Furfine, Mary H Hanlon, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2009
Substituted tetrahydro-beta-carbolines as potential agents for the treatment of human papillomavirus infectionJohn F Miller, Elizabeth M Turner, Ronald G Sherrill, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2005
Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitorsRonald G Sherrill, Eric S Furfine, Richard J Hazen, et al.
Bioorganic & Medicinal Chemistry Letters|July 31, 2009
Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1Kristjan S Gudmundsson, Paul R Sebahar, Leah D'Aurora Richardson, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2010
Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1John G Catalano, Kristjan S Gudmundsson, Angilique Svolto, et al.
Journal of Medicinal Chemistry|November 15, 2013
Imidazopyridazine hepatitis C virus polymerase inhibitors. Structure-activity relationship studies and the discovery of a novel, traceless prodrug mechanismMartin Leivers, John F Miller, Stephanie A Chan, et al.
Biochemistry|November 10, 2004
Inhibition of wild-type and mutant human immunodeficiency virus type 1 proteases by GW0385 and other arylsulfonamidesMary H Hanlon, David J T Porter, Eric S Furfine, et al.
The Journal of Organic Chemistry|November 1, 2013
Synthesis of HCV replicase inhibitors: base-catalyzed synthesis of protected α-hydrazino esters and selective aerobic oxidation with catalytic Pt/Bi/C for synthesis of imidazole-4,5-dicarbaldehydeRoy K Bowman, Andrew D Brown, Jannine H Cobb, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2006
Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385John F Miller, C Webster Andrews, Michael Brieger, et al.
Pageof 3